IMMUNOGEN, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

ITEM 2.02 - RESULTS OF OPERATION AND FINANCIAL CONDITION

On February 14, 2020, ImmunoGen, Inc. (Nasdaq: IMGN) issued a press release to announce the company's financial results for the quarter and year ended December 31, 2019. The press release announcing financial results for the quarter and year ended December 31, 2019 is included as Exhibit 99.1 and incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d): Exhibits



Exhibit No.     Exhibit

    99.1          Press Release of ImmunoGen, Inc. dated February 14, 2020

    104         Cover Page Interactive Data File (embedded within the Inline XBRL
                (eXtensible Business Reporting Language) document).

© Edgar Online, source Glimpses